A nationwide analysis reveals that metastatic status significantly influences the survival outcomes of patients with malignant peripheral nerve sheath tumors receiving neoadjuvant radiotherapy. This study provides critical insights into treatment efficacy based on disease progression.
metastatic status modifies the survival association of neoadjuvant radiotherapy in malignant peripheral nerve sheath tumors a nationwide analysis
Original title: “Metastatic Status Modifies the Survival Association of Neoadjuvant Radiotherapy in Malignant Peripheral Nerve Sheath Tumors: A Nationwide Analysis.”